Detalles de la búsqueda
1.
Direct comparison of risankizumab and fumaric acid esters in systemic therapy-naïve patients with moderate-to-severe plaque psoriasis: a randomized controlled trial.
Br J Dermatol
; 186(1): 30-39, 2022 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-33991341
2.
Patient-reported outcomes with risankizumab versus fumaric acid esters in systemic therapy-naïve patients with moderate to severe plaque psoriasis: a phase 3 clinical trial.
J Eur Acad Dermatol Venereol
; 35(8): 1686-1691, 2021 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-33428281
3.
Adalimumab medium-term dosing strategy in moderate-to-severe hidradenitis suppurativa: integrated results from the phase III randomized placebo-controlled PIONEER trials.
Br J Dermatol
; 181(5): 967-975, 2019 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-30916379
4.
Sustained long-term efficacy and safety of adalimumab in paediatric patients with severe chronic plaque psoriasis from a randomized, double-blind, phase III study.
Br J Dermatol
; 181(6): 1177-1189, 2019 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-31017657
5.
Dark material on Vesta from the infall of carbonaceous volatile-rich material.
Nature
; 491(7422): 83-6, 2012 Nov 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-23128228
6.
Prognostic implications of baseline anaemia and changes in haemoglobin concentrations with amphotericin B therapy for cryptococcal meningitis.
HIV Med
; 18(1): 13-20, 2017 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-27126930
7.
Pitted terrains on (1) Ceres and implications for shallow subsurface volatile distribution.
Geophys Res Lett
; 44(13): 6570-6578, 2017 07 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-28989206
8.
HiSCR (Hidradenitis Suppurativa Clinical Response): a novel clinical endpoint to evaluate therapeutic outcomes in patients with hidradenitis suppurativa from the placebo-controlled portion of a phase 2 adalimumab study.
J Eur Acad Dermatol Venereol
; 30(6): 989-94, 2016 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-26201313
9.
Changes in C-reactive protein in patients with moderate-to-severe psoriasis switched to adalimumab therapy after suboptimal response to etanercept, methotrexate or phototherapy.
J Eur Acad Dermatol Venereol
; 28(12): 1701-6, 2014 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-24422992
10.
Effects of briakinumab treatment for moderate to severe psoriasis on health-related quality of life and work productivity and activity impairment: results from a randomized phase III study.
J Eur Acad Dermatol Venereol
; 28(6): 790-8, 2014 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-23679896
11.
Confocal microphotoluminescence mapping of coupled and detuned states in photonic molecules.
Opt Express
; 21(14): 16934-45, 2013 Jul 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-23938542
12.
Mouse model of X-linked chronic granulomatous disease, an inherited defect in phagocyte superoxide production.
Nat Genet
; 9(2): 202-9, 1995 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-7719350
13.
Mutant GABA(A) receptor gamma2-subunit in childhood absence epilepsy and febrile seizures.
Nat Genet
; 28(1): 49-52, 2001 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-11326275
14.
Visible to Near-Infrared Reflectance Spectroscopy of Asteroid (16) Psyche: Implications for the Psyche Mission's Science Investigations.
Earth Space Sci
; 10(1): e2022EA002694, 2023 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-37034273
15.
Scale-up and manufacturing of clinical-grade self-inactivating γ-retroviral vectors by transient transfection.
Gene Ther
; 19(3): 246-54, 2012 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-21753795
16.
Critical variables affecting clinical-grade production of the self-inactivating gamma-retroviral vector for the treatment of X-linked severe combined immunodeficiency.
Gene Ther
; 19(8): 872-6, 2012 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-22551777
17.
Changes in hippocampal GABAA/cBZR density during limbic epileptogenesis: relationship to cell loss and mossy fibre sprouting.
Neurobiol Dis
; 41(2): 227-36, 2011 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-20816783
18.
Efficacy and safety of briakinumab vs. etanercept and placebo in patients with moderate to severe chronic plaque psoriasis.
Br J Dermatol
; 165(3): 652-60, 2011 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-21574983
19.
Efficacy and safety results from a phase III, randomized controlled trial comparing the safety and efficacy of briakinumab with etanercept and placebo in patients with moderate to severe chronic plaque psoriasis.
Br J Dermatol
; 165(3): 661-8, 2011 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-21574984
20.
Colocalization of retrovirus and target cells on specific fibronectin fragments increases genetic transduction of mammalian cells.
Nat Med
; 2(8): 876-82, 1996 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-8705856